Dexcom (DXCM-Q)
NASDAQ:DXCM
85.67
0.85
(0.98%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await Nvidia
This summary was created by AI, based on 2 opinions in the last 12 months.
Dexcom (DXCM-Q) has faced a challenging period, particularly highlighted by its recent quarterly performance, which has raised concerns among investors and analysts alike. The latest reports indicate that the company not only posted disappointing results but also failed to provide a thorough explanation for the underperformance, leading to a decline in investor confidence. This uncertainty surrounding the company's growth prospects and transparency in communication has caused many to reassess their positions on the stock. As Dexcom navigates these turbulent waters, market participants are looking for clearer guidance and a turnaround strategy. Investors are keenly watching for updates that could either restore faith in the company's trajectory or confirm their apprehensions about its future potential.
DXCM has been hit hard as investors fear new success of weight loss drugs will reduce demand for diabetes monitoring products. DXCM is not alone in the decline. But it is still growing, and recent comments by analysts suggest the sell off is quite overdone. It has new products on tap and is strong financially. Market share remains robust. Best Buy has started selling its products (not material on its own, but shows an expanding footprint). We would see DXCM as worth holding. Because it is 33X as large was WELL, they are hard to compare. WELL, being smaller, could potentially rise more, but comes with much more overall risk. From a safety and valuation standpoint, we would, today, prefer DXCM.
Unlock Premium - Try 5i Free
- «
- ‹
- 1
- ›
- »
Dexcom(DXCM-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 2
Total Signals / Votes : 2
Dexcom(DXCM-Q) Frequently Asked Questions
What is Dexcom stock symbol?
Dexcom is a American stock, trading under the symbol DXCM-Q on the NASDAQ (DXCM). It is usually referred to as NASDAQ:DXCM or DXCM-Q
Is Dexcom a buy or a sell?
In the last year, 2 stock analysts published opinions about DXCM-Q. 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Dexcom.
Is Dexcom a good investment or a top pick?
Dexcom was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Dexcom.
Why is Dexcom stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Dexcom worth watching?
2 stock analysts on Stockchase covered Dexcom In the last year. It is a trending stock that is worth watching.
What is Dexcom stock price?
On 2025-05-15, Dexcom (DXCM-Q) stock closed at a price of $85.67.
Their last quarter was very bad. He lost faith.